Calvin Sandra
CIK: 0001882909•SVP, CHIEF ACCOUNTING OFFICER
Officer
Primary company: Travere Therapeutics, Inc. (TVTX)
Calvin Sandra is a corporate insider (SVP, CHIEF ACCOUNTING OFFICER) at Travere Therapeutics, Inc. (TVTX) filing SEC Form 4 transactions. 59 transactions, totaling $0 in purchases and $5,059,591 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 6,500 | $20.46 | $133K | 19,500 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Exercise | 6,250 | $8.93 | $56K | 12,500 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Exercise | 2,500 | $22.40 | $56K | 5,000 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Sale | 21,977 | $41.07 | $903K | 42,353 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Exercise | 6,500 | $20.46 | $133K | 64,330 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Exercise | 6,250 | $8.93 | $56K | 57,830 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Exercise | 2,500 | $22.40 | $56K | 51,580 | 4/14/2026 Filed: 4/16/2026 | Filing → | |
| Sale | 4,333 | $32.12 | $139K | 49,080 | 2/3/2026 Filed: 1/31/2026 | Filing → | |
| Award | 20,160 | $33.09 | $667K | 20,160 | 1/31/2026 Filed: 1/31/2026 | Filing → | |
| Award | 15,180 | - | - | 53,413 | 1/31/2026 Filed: 1/31/2026 | Filing → | |
| Sale | 7,402 | $40.00 | $296K | 38,233 | 12/24/2025 Filed: 12/29/2025 | Filing → | |
| Sale | 2,910 | $36.00 | $105K | 45,635 | 12/15/2025 Filed: 12/16/2025 | Filing → | |
| Exercise | 6,250 | - | - | 18,750 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Exercise | 12,500 | - | - | 7,500 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Exercise | 15,000 | - | - | 2,500 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Exercise | 17,500 | - | - | 0 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Exercise | 10,000 | - | - | 0 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Sale | 67,115 | $36.00 | $2.42M | 48,545 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Exercise | 6,250 | $8.93 | $56K | 115,660 | 11/4/2025 Filed: 11/6/2025 | Filing → | |
| Exercise | 12,500 | $22.40 | $280K | 109,410 | 11/4/2025 Filed: 11/6/2025 | Filing → |
Type
Exercise
Shares
6,500
Price
$20.46
Value
$133K
Type
Exercise
Shares
6,250
Price
$8.93
Value
$56K
Type
Exercise
Shares
2,500
Price
$22.40
Value
$56K
Type
Sale
Shares
21,977
Price
$41.07
Value
$903K
Type
Exercise
Shares
6,500
Price
$20.46
Value
$133K
Type
Exercise
Shares
6,250
Price
$8.93
Value
$56K
Type
Exercise
Shares
2,500
Price
$22.40
Value
$56K
Type
Sale
Shares
4,333
Price
$32.12
Value
$139K
Type
Award
Shares
20,160
Price
$33.09
Value
$667K
Type
Award
Shares
15,180
Price
-
Value
-
Type
Sale
Shares
7,402
Price
$40.00
Value
$296K
Type
Sale
Shares
2,910
Price
$36.00
Value
$105K
Type
Exercise
Shares
6,250
Price
-
Value
-
Type
Exercise
Shares
12,500
Price
-
Value
-
Type
Exercise
Shares
15,000
Price
-
Value
-
Type
Exercise
Shares
17,500
Price
-
Value
-
Type
Exercise
Shares
10,000
Price
-
Value
-
Type
Sale
Shares
67,115
Price
$36.00
Value
$2.42M
Type
Exercise
Shares
6,250
Price
$8.93
Value
$56K
Type
Exercise
Shares
12,500
Price
$22.40
Value
$280K
AI Agent
Try asking...